Bellwether Advisors LLC Acquires 182 Shares of The Clorox Company (NYSE:CLX)

Bellwether Advisors LLC lifted its holdings in The Clorox Company (NYSE:CLX) by 1.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,366 shares of the company’s stock after purchasing an additional 182 shares during the quarter. Bellwether Advisors LLC’s holdings in Clorox were worth $1,684,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in Clorox in the third quarter worth approximately $714,000. Diamant Asset Management Inc. grew its stake in shares of Clorox by 12.5% during the 3rd quarter. Diamant Asset Management Inc. now owns 2,250 shares of the company’s stock valued at $367,000 after purchasing an additional 250 shares during the period. Wilmington Savings Fund Society FSB boosted its holdings in shares of Clorox by 12.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 10,366 shares of the company’s stock worth $1,689,000 after buying an additional 1,150 shares during the last quarter. Tidal Investments LLC raised its position in Clorox by 1.3% in the third quarter. Tidal Investments LLC now owns 29,913 shares of the company’s stock worth $4,873,000 after acquiring an additional 393 shares during the period. Finally, Franklin Resources Inc. increased its stake in shares of Clorox by 10.4% in the 3rd quarter. Franklin Resources Inc. now owns 135,225 shares of the company’s stock worth $21,840,000 after purchasing an additional 12,776 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Up 0.5 %

CLX stock opened at $138.28 on Monday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm’s 50-day moving average is $145.61 and its 200 day moving average is $155.63. The company has a market capitalization of $17.03 billion, a PE ratio of 37.78, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the business posted $2.16 EPS. On average, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.53%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.

Analyst Ratings Changes

CLX has been the subject of several recent research reports. UBS Group cut their price target on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. JPMorgan Chase & Co. lowered their price target on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating on the stock in a report on Friday, April 11th. Citigroup decreased their price objective on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, Wells Fargo & Company decreased their target price on Clorox from $155.00 to $145.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 16th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.